Lv41
586 积分 2025-11-18 加入
Preclinical Evaluation of IMGC936, a Next-Generation Maytansinoid-based Antibody–drug Conjugate Targeting ADAM9-expressing Tumors
7小时前
已完结
Preclinical Development of MGC028, an ADAM9-Targeted, Glycan-Linked, Exatecan-Based Antibody–Drug Conjugate for the Treatment of Solid Cancers
7小时前
已完结
ADAM9: an updated view of its biology and pathology
7小时前
已完结
PF-08046876, a differentiated integrin beta-6 antibody-drug conjugate delivering a potent camptothecin payload optimized for bystander effect and reduced drug efflux
12天前
已完结
Systematic research of peptide spacers controlling drug release from macromolecular prodrug system, carboxymethyldextran polyalcohol-peptide-drug conjugates
1个月前
已完结
Development of potent monoclonal antibody auristatin conjugates for cancer therapy
1个月前
已完结
Cathepsin B-Labile Dipeptide Linkers for Lysosomal Release of Doxorubicin from Internalizing Immunoconjugates: Model Studies of Enzymatic Drug Release and Antigen-Specific In Vitro Anticancer Activity
1个月前
已完结
Pharmacokinetic Considerations for Antibody-Drug Conjugates against Cancer
1个月前
已完结
Strategies and challenges for the next generation of antibody–drug conjugates
1个月前
已完结
Antibody–drug conjugates for cancer
1个月前
已完结
皖公网安备34019202002308
